We are live on ! Find out more
CWM

Cahill Wealth Management Portfolio holdings

AUM $196M
1-Year Est. Return 8.5%
This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+8.5%
3 Year Est. Return
+24.65%
5 Year Est. Return
10 Year Est. Return
AUM
$196M
AUM Growth
+$407K
Cap. Flow
+$6.94M
Cap. Flow %
3.53%
Top 10 Hldgs %
78.11%
Holding
50
New
1
Increased
22
Reduced
16
Closed
1

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.15%
2 Financials 7.67%
3 Healthcare 3.33%
4 Technology 2.12%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
26
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$872K 0.44%
3,932
-94
-2% -$22.4K
SCZ icon
27
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$825K 0.42%
12,979
-41
-0.3% -$2.59K
DFAU icon
28
Dimensional US Core Equity Market ETF
DFAU
$12.8B
$753K 0.38%
19,581
-33
-0.2% -$1.34K
VOO icon
29
Vanguard S&P 500 ETF
VOO
$1.03T
$681K 0.35%
1,326
+4
+0.3% +$2.16K
VEA icon
30
Vanguard FTSE Developed Markets ETF
VEA
$239B
$670K 0.34%
13,175
+34
+0.3% +$1.72K
AMZN icon
31
Amazon
AMZN
$2.76T
$647K 0.33%
3,399
VOT icon
32
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$641K 0.33%
2,620
+3
+0.1% +$780
AQST icon
33
Aquestive Therapeutics
AQST
$648M
$633K 0.32%
218,381
+75,330
+53% +$228K
TMDX icon
34
Transmedics
TMDX
$3.18B
$605K 0.31%
8,987
+3,067
+52% +$211K
DFIS icon
35
Dimensional International Small Cap ETF
DFIS
$5.98B
$583K 0.3%
22,570
-162
-0.7% -$4.14K
VKTX icon
36
Viking Therapeutics
VKTX
$3.95B
$514K 0.26%
21,286
+5,991
+39% +$189K
VRNA
37
DELISTED
Verona Pharma
VRNA
$512K 0.26%
8,060
+315
+4% +$18.8K
DUSB icon
38
Dimensional Ultrashort Fixed Income ETF
DUSB
$2.24B
$504K 0.26%
+9,933
New +$504K
IWF icon
39
iShares Russell 1000 Growth ETF
IWF
$127B
$502K 0.26%
5,560
VEU icon
40
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$457K 0.23%
7,542
-198
-3% -$11.9K
VCSH icon
41
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$447K 0.23%
5,658
VBR icon
42
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.8B
$386K 0.2%
2,072
IWP icon
43
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
$329K 0.17%
2,800
COST icon
44
Costco
COST
$415B
$319K 0.16%
337
+20
+6% +$19.5K
VCLT icon
45
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.85B
$243K 0.12%
3,200
ZTS icon
46
Zoetis
ZTS
$31B
$240K 0.12%
1,455
+1
+0.1% +$166
WMT icon
47
Walmart Inc
WMT
$817B
$237K 0.12%
2,705
-474
-15% -$44.5K
IEFA icon
48
iShares Core MSCI EAFE ETF
IEFA
$195B
$232K 0.12%
3,061
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.17T
$225K 0.11%
1,452
-200
-12% -$36.3K
ESGV icon
50
Vanguard ESG US Stock ETF
ESGV
$13.7B
-1,921
Closed -$202K

Similar funds

Cahill Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, Cahill Wealth Management held 50 positions worth $196M, up 0.21% from $196M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Cahill Wealth Management deployed $6.94M of net new capital in Q1 2025, opening 1 new position and adding to 22 existing holdings. Its largest new stake was Dimensional Ultrashort Fixed Income ETF: 9,933 shares worth $504K.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 86% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Stryker, an estimated $413K trimmed.

  • Cahill Wealth Management's largest Q1 2025 buy was Dimensional Ultrashort Fixed Income ETF: 9,933 shares worth $504K.
  • Cahill Wealth Management added most to Dimensional US Core Equity 2 ETF in Q1 2025, an estimated $2.74M increase.
  • Cahill Wealth Management's biggest Q1 2025 reduction was Stryker, cutting an estimated $413K.
  • Cahill Wealth Management fully exited Vanguard ESG US Stock ETF in Q1 2025, selling an estimated $202K.
  • Cahill Wealth Management's ten largest holdings make up 78% of its $196M portfolio in Q1 2025.
  • Cahill Wealth Management opened 1 new position and closed 1 in Q1 2025.
  • Cahill Wealth Management's portfolio value rose 0.21% quarter-over-quarter to $196M.

Based on Cahill Wealth Management's 13F filing for Q1 2025, filed 12 May 2025.